Cefrowice 500
Cefuroxime (500mg)

About this product
Trusted Second-Generation Cephalosporin. Established across respiratory, ENT, urinary, and skin infections.

Overview
Cefrowice 500 addresses outpatient bacterial infections, and as a second-generation cephalosporin, it remains active against many beta-lactamase-producing strains. It offers established efficacy across respiratory, ENT, urinary, and skin/soft-tissue infections in everyday outpatient practice. It also provides a practical oral step-down option after initial IV cephalosporin treatment, and brings the reliability of a long-standing, well-established second-generation cephalosporin with an extensive clinical track record.
Indications
Related Products

Aztronaz 1g
Aztreonam (1gm)
Targeted gram-negative coverage against E. coli, Klebsiella, and Pseudomonas for serious UTI, respiratory, intra-abdominal, gynaecological, skin, and bloodstream infections.

Cilbactam 1.5
Ampicillin (1gm) + Sulbactam (500mg)
Broad single-agent coverage against gram-positive, gram-negative, and anaerobic infections, including skin, intra-abdominal, and gynaecological infections such as PID and endometritis.
Partner With Schemic Concepts
Engineer better health outcomes with precision-driven pharmaceuticals
Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it